PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AFTER ANTI-TNF-ALFATHERAPY IN HUNGARY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64939-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64939-X/fulltext
Title :
PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AFTER ANTI-TNF-ALFATHERAPY IN HUNGARY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64939-X&doi=10.1016/S1098-3015(10)64939-X
First page :
Section Title :
Open access? :
No
Section Order :
98